全文获取类型
收费全文 | 612篇 |
免费 | 23篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 6篇 |
妇产科学 | 8篇 |
基础医学 | 63篇 |
口腔科学 | 5篇 |
临床医学 | 29篇 |
内科学 | 246篇 |
皮肤病学 | 3篇 |
神经病学 | 26篇 |
特种医学 | 23篇 |
外科学 | 97篇 |
综合类 | 9篇 |
一般理论 | 1篇 |
预防医学 | 26篇 |
眼科学 | 22篇 |
药学 | 38篇 |
中国医学 | 1篇 |
肿瘤学 | 33篇 |
出版年
2023年 | 2篇 |
2022年 | 14篇 |
2021年 | 13篇 |
2020年 | 2篇 |
2019年 | 10篇 |
2018年 | 13篇 |
2017年 | 11篇 |
2016年 | 4篇 |
2015年 | 6篇 |
2014年 | 7篇 |
2013年 | 8篇 |
2012年 | 24篇 |
2011年 | 26篇 |
2010年 | 16篇 |
2009年 | 20篇 |
2008年 | 33篇 |
2007年 | 26篇 |
2006年 | 35篇 |
2005年 | 36篇 |
2004年 | 25篇 |
2003年 | 25篇 |
2002年 | 19篇 |
2001年 | 34篇 |
2000年 | 31篇 |
1999年 | 24篇 |
1998年 | 6篇 |
1997年 | 3篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1992年 | 16篇 |
1991年 | 14篇 |
1990年 | 15篇 |
1989年 | 10篇 |
1988年 | 16篇 |
1987年 | 10篇 |
1986年 | 12篇 |
1985年 | 11篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 5篇 |
1975年 | 3篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1969年 | 2篇 |
1966年 | 2篇 |
排序方式: 共有637条查询结果,搜索用时 0 毫秒
631.
632.
633.
A prospective study of the clinical efficacy of an aminoglycoside antibiotic (streptomycin, SM) for the treatment of pulmonary Mycobacterium avium complex (MAC) disease was carried out. In a multicenter trial, patients with pulmonary MAC disease received protocol-guided combined chemotherapy with or without SM. SM was given to the patients intramuscularly 15 mg/kg three times per week for the initial 3 months and three other antibiotics (rifampicin, ethambutol, and clarithromycin) were added and administered for over 24 months after the conversion of MAC strains. From April 1998 to December 2004, 160 HIV-negative patients were enrolled in this trial. Fourteen patients were found to be ineligible because they could not continue the treatment, and they were excluded from the analysis after randomization. Seventy-three patients were assigned to receive combined chemotherapy with SM (group A) and 73 were assigned to receive combined chemotherapy without SM (group B). The median durations of treatment were 27.6 months in group A and 28.4 months in group B. The difference in the backgrounds of the groups was not statistically significant. There were no differences in microbiological and radiological findings between the groups, but the sputum conversion rate for pulmonary MAC disease at the completion of treatment was significantly higher in group A than that in group B. Although, there were no significant differences in the sputum relapse rate and clinical improvement including both clinical symptoms and radiological findings, group A showed better initial microbiological response than group B. As for adverse reactions and abnormal laboratory findings, there were no significant differences between the groups. Based on the results of this double-blind randomized study, we support treatment including SM according to both the American Thoracic Society (ATS) and the Japanese Society for Tuberculosis (JST) guidelines for patients with pulmonary MAC disease without HIV infection. 相似文献
634.
Minimum 24-month followup of the sling for the treatment of stress urinary incontinence 总被引:1,自引:0,他引:1
Nazemi TM Yamada B Govier FE Kuznetsov DD Kodama K Kobashi KC 《The Journal of urology》2008,179(2):596-599
635.
636.
637.
Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. 总被引:13,自引:0,他引:13
G Kobashi H Yamada K Ohta E Kato Y Ebina S Fujimoto 《American journal of medical genetics》2001,103(3):241-244
Hypertension in pregnancy (HP), including preeclampsia, is known to be a multifactorial disease. Recently, a Glu298Asp variant of the endothelial nitric oxide synthase gene (NOS3) was identified as being associated with coronary spasm and myocardial infarction, whereas it has been reported that endothelial nitric oxide synthase plays a role in HP. We therefore performed an association study of the Glu298Asp variant with HP among 152 HP patients and 335 normal pregnant control individuals, in the context of other risk factors before pregnancy. The frequency of the variant GA+AA NOS3 genotypes was significantly higher in the patients (0.23) than in the controls (0.12) (P < 0.01). Multivariate analysis revealed that family history of hypertension, TT genotype of the angiotensinogen gene (AGT), GA+AA NOS3 genotype, and prepregnancy body mass index > or = 24 were independent potent risk factors, after adjustment for maternal age and parity. The odds ratios of the factors were 2.7, 2.3, 2.2, and 2.1, respectively. Our results suggested that the Asp298 of NOS3 is a potent, independent risk factor for HP. 相似文献